TETRAPHASE PHARMACEUTICALS INC Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
TETRAPHASE PHARMACEUTICALS INC reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 59.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2016-02-25
- TETRAPHASE PHARMACEUTICALS INC fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 59.00%, a 0.00% change from fiscal 2014.
- TETRAPHASE PHARMACEUTICALS INC fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2014 was 59.00%, a 0.00% change from fiscal 2013.
- TETRAPHASE PHARMACEUTICALS INC fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 59.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2015-12-31 | 59.00% 10-K · filed 2016-02-25 | ||
| 2014-12-31 | 59.00% 10-K · filed 2015-03-06 | ||
| 2013-12-31 | 59.00% 10-K · filed 2014-03-06 | ||
| 2013-09-30 | 59.00% 10-Q · filed 2013-11-14 | ||
| 2013-02-28 | 59.00% 10-K · filed 2016-02-25 |